Results of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy after early failure of adjuvant systemic chemotherapy

Failure to respond to systemic chemotherapy is considered an exclusion criterion by some institutions for treatment with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC). However, it is unknown if these patients benefit from HIPEC treatment. This study aimed to report on outcomes of HIPEC in patients who failed to respond to adjuvant systemic chemotherapy.

[1]  D. Elias,et al.  Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  S. Bruin,et al.  8-Year Follow-up of Randomized Trial: Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy Versus Systemic Chemotherapy in Patients with Peritoneal Carcinomatosis of Colorectal Cancer , 2008, Annals of Surgical Oncology.

[3]  A. Agha,et al.  Multimodality treatment of peritoneal carcinomatosis from colorectal cancer: first results of a new German centre for peritoneal surface malignancies , 2007, International Journal of Colorectal Disease.

[4]  Franck Molina,et al.  Gene expression signature in advanced colorectal cancer patients select drugs and response for the use of leucovorin, fluorouracil, and irinotecan. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  H. Boot,et al.  Conventional surgery and systemic chemotherapy for peritoneal carcinomatosis of colorectal origin: a prospective study. , 2005, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[6]  J. Berlin,et al.  Bevacizumab in combination with fluorouracil and leucovorin: an active regimen for first-line metastatic colorectal cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  M. Ceranic,et al.  Treatment of peritoneal carcinomatosis from colorectal cancer by cytoreductive surgery and hyperthermic perioperative intraperitoneal chemotherapy. , 2005, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[8]  F. Kwiatkowski,et al.  Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  Armando Santoro,et al.  Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer. , 2004, The New England journal of medicine.

[10]  E. Cotte,et al.  Intraperitoneal chemohyperthermia and attempted cytoreductive surgery in patients with peritoneal carcinomatosis of colorectal origin , 2004, The British journal of surgery.

[11]  M. Pocard,et al.  Treatment of Peritoneal Carcinomatosis From Colorectal Cancer: Impact of Complete Cytoreductive Surgery and Difficulties in Conducting Randomized Trials , 2004, Annals of Surgical Oncology.

[12]  K. Geisinger,et al.  Cytoreductive Surgery and Intraperitoneal Hyperthermic Chemotherapy With Mitomycin C for Peritoneal Carcinomatosis from Nonappendiceal Colorectal Carcinoma , 2004, Annals of Surgical Oncology.

[13]  L. Påhlman,et al.  Improved survival in patients with peritoneal metastases from colorectal cancer: a preliminary study , 2004, British Journal of Cancer.

[14]  H. van Tinteren,et al.  Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  M. Katz,et al.  The rationale of perioperative intraperitoneal chemotherapy in the treatment of peritoneal surface malignancies. , 2003, Surgical oncology clinics of North America.

[16]  R. Sticca,et al.  Rationale for hyperthermia with intraoperative intraperitoneal chemotherapy agents. , 2003, Surgical oncology clinics of North America.

[17]  S. Mocellin,et al.  Cytoreductive Surgery Combined With Hyperthermic Intraperitoneal Intraoperative Chemotherapy for Peritoneal Carcinomatosis Arising From Colon Adenocarcinoma , 2003, Annals of Surgical Oncology.

[18]  P. Sugarbaker.  Carcinomatosis--is cure an option? , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  J P Pignon,et al.  Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. , 2001, The New England journal of medicine.

[20]  L. Saltz,et al.  Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group. , 2000, The New England journal of medicine.

[21]  C. Wilson,et al.  Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  H. Juhl,et al.  Isolated tumor cells are frequently detectable in the peritoneal cavity of gastric and colorectal cancer patients and serve as a new prognostic marker. , 1998, Annals of surgery.

[23]  P. Sugarbaker.  Peritonectomy Procedures , 1995, Surgical oncology clinics of North America.

[24]  W. Cunliffe,et al.  Early postoperative intraperitoneal chemotherapy as an adjuvant therapy to surgery for peritoneal carcinomatosis from gastrointestinal cancer: pharmacological studies. , 1990, Cancer research.

[25]  C. Köhne,et al.  Systemic chemotherapy in patients with peritoneal carcinomatosis from colorectal cancer. , 2007, Cancer treatment and research.

[26]  Junyang Sim BSc,et al.  Selection of Patients with Colorectal Peritoneal Carcinomatosis for Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy , 2007, Annals of Surgical Oncology.

[27]  E. Martin,et al.  Intraperitoneal hyperthermic perfusion with mitomycin C for colorectal cancer with peritoneal metastases , 2006, Annals of Surgical Oncology.